Baxter Pharmaceuticals India Private Limited, a active private limited company, was established on 08 June 2005 in Vasana Chacharwadi, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2005PTC046211. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2,000.00 Cr and a paid-up capital of ₹0.57 M.
Formerly known as Claris Injectables Limited, Claris Lifesciences International Limited. It upholds a compliant status. Employing 1,179 professional, Its leadership includes Sanju Dhawan (Director), Anuranjan Naresh (Additional Director), Tripti Sapra (Additional Director). Past directors included Rishikesh Satish Jaiwant, Chandrasingh Shivrambhai Purohit, Arjun Sushilkumar Handa. It holds ₹5.00 Cr open charges and ₹1,130.21 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Village : Vasana-Chacharwadi Tal : Sanand, Vasana Chacharwadi, Gujarat, 382213.
U24230GJ2005PTC046211
046211
08 June 2005
₹2,000.00 Cr
₹0.57 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Baxter Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanju Dhawan | Director | 09 Jul 2021 | Current |
| Anuranjan Naresh | Additional Director | 01 Oct 2024 | Current |
| Tripti Sapra | Additional Director | 01 Oct 2024 | Current |
| Ashwin Prakash Upasane | Additional Director | 18 Jun 2025 | Current |
| Anurag Bharatkumar Pachchigar | Additional Director | 01 Oct 2024 | Current |
| Gurjeet Singh Bedi | Additional Director | 23 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 27 Jul 2017 | Past |
| Pramod Abcsdd | Director | 27 Jul 2017 | Past |
| Pramod Abcsdd | Director | 01 Aug 2014 | Past |
| Pramod Abcsdd | Additional Director | 31 Jul 2017 | Past |
| Pramod Abcsdd | Director | 10 Jan 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Baxter Pharmaceuticals India Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 11.17% decrease. The company also saw a substantial improvement in profitability, with a 56.37% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Baxter Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹50,000,000.00
₹11,302,077,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jul 2019 | Uco Bank | ₹5.00 Cr | Open |
| 29 Mar 2016 | Others | ₹1.18 M | Satisfied |
| 19 Sep 2015 | Others | ₹0.70 M | Satisfied |
| 18 Sep 2015 | Others | ₹1.00 M | Satisfied |
| 31 Oct 2014 | Canara Bank | ₹564.96 Cr | Satisfied |
Explore comprehensive loan charge details -
Baxter Pharmaceuticals India has a workforce of 1179 employees as of Oct 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Baxter Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baxter Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ashwin Prakash Upasane was appointed as a Additional Director was appointed as a Additional Director on 18 Jun 2025 & has been associated with this company since 5 months 14 days . was recorded as a recent event.
Gurjeet Singh Bedi was appointed as a Additional Director was appointed as a Additional Director on 23 Dec 2024 & has been associated with this company since 11 months 8 days . was recorded as a recent event.
The activity Anuranjan Naresh was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2024 & has been associated with this company since 1 year 2 months . was completed.
Tripti Sapra was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2024 & has been associated with this company since 1 year 2 months . was recorded as a recent event.
Progress on Anurag Bharatkumar Pachchigar was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity Baxter Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Chennai: Pharma Major, Caplin Point Laboratories said that its wholly owned subsidiary Caplin Steriles Limited has entered into a license and supply agreement with Baxter Healthcare Corporation .
The CIN of Baxter Pharmaceuticals India Private Limited is U24230GJ2005PTC046211.
Baxter Pharmaceuticals India Private Limited is headquartered at Village : Vasana-Chacharwadi Tal : Sanand, Vasana Chacharwadi, Gujarat, 382213.
Baxter Pharmaceuticals India Private Limited was incorporated on 08 June 2005.
The current directors of Baxter Pharmaceuticals India Private Limited are
The primary industry of Baxter Pharmaceuticals India Private Limited is Manufacturing.
Baxter Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Baxter Pharmaceuticals India Private Limited is ₹2,000.00 Cr, and the paid-up capital is ₹0.57 M.
The compliance status of Baxter Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX